Compare Allbirds Inc (BIRD) vs Danaher Corporation (DHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Danaher Corporation — how do they compare? Allbirds Inc trades at $2.97 (market cap $26.33M), while Danaher Corporation trades at $199.47 (market cap $141.67B). The key difference: Danaher Corporation is far larger — about 5380.6× Allbirds Inc's market cap, and Danaher Corporation pays a 0.8% dividend while Allbirds Inc pays none. Which is the better fit depends on your goals.
| BIRD | DHR | |
|---|---|---|
Market Cap | $26.33M | $141.67B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $242.05 |
52-Week Low | $2.39 | $161.91 |
Enterprise Value | $45.20M | $154.45B |
Dividend Yield | — | 0.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIRD (Smartbird) trades at $3.00, down 4.15% today, amid a complete pivot from footwear to AI infrastructure. The stock shows a bearish technical signal with flat support/resistance at $3.00, while oscillators like RSI indicate oversold conditions. Financially, revenue has declined from $298M in 2022 to $152M in 2025, with persistent net losses and negative cash flow. Recent news highlights the rebrand to Smartbird and new CEO appointment, driving volatility.
The outlook is highly speculative; the AI pivot offers growth potential but execution risks are severe given the company's unprofitable history and cash burn. Analyst consensus is cautious with 79% hold ratings. Investors face significant uncertainty around the new business model's viability and funding needs.
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →
